Scientists said Pfizer’s RSV vaccine for older adults should be monitored for Guillain-Barre, in an article published in the New England Journal of Medicine.
Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccine’s list price to $130.
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
Sen. Bernie Sanders, in a letter to the CEO, slammed the proposed price hike as “outrageous” given that the vaccine was developed using taxpayer money.
Currently, Pfizer’s and Moderna’s omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.
RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.
Pfizer said the FDA has accepted its RSV vaccine candidate for review under an expedited process that reduces the approval process by four months.
New research suggests that exercise is associated with higher effectiveness of Covid-19 vaccines and more protection from severe outcomes. Here’s what we know.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}